• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-125b 促进尤文肉瘤/原始神经外胚层肿瘤的化疗耐药性。

miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor.

机构信息

Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Maidashi3-1-1, Fukuoka, 812-8582, Japan.

出版信息

Cancer Cell Int. 2013 Mar 4;13(1):21. doi: 10.1186/1475-2867-13-21.

DOI:10.1186/1475-2867-13-21
PMID:23497288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3599506/
Abstract

BACKGROUND

Diverse functions of microRNAs (miRNAs), including effects on tumorigenesis, proliferation, and differentiation, have been reported, and several miRNAs have also been demonstrated to play an important role in apoptosis. In this study, we investigated the possible role that miRNAs may play in the development of chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor (EWS).

METHODS

We screened doxorubicin (Dox)-resistant EWS cells to identify any distinct miRNA sequences that may regulate the chemoresistance of EWS cells. The effects of miRNAs were evaluated using a chemosensitivity assay. The possible target genes of the miRNAs were predicted using a web-based prediction program.

RESULTS

We found miR-125b to be upregulated in two different Dox-resistant EWS cell lines. The upregulation of miR-125b was also confirmed in the EWS tumors having survived chemotherapy regimen which includes doxorubicin. When miR-125b was knocked down in EWS cells, both the Dox-resistant and parental cells showed an enhanced sensitivity to doxorubicin, which was associated with the upregulation of the pro-apoptotic molecules, p53 and Bak. Inversely, the overexpression of miR-125b in parental EWS cells resulted in enhanced drug resistance, not only to doxorubicin, but also to etoposide and vincristine.

CONCLUSIONS

Our findings suggest that miR-125b may play a role in the development of chemoresistance in EWS by suppressing the expression of the apoptotic mediators, such as p53 and Bak.

摘要

背景

微小 RNA(miRNA)具有多种功能,包括对肿瘤发生、增殖和分化的影响,并且已经证实几种 miRNA 在细胞凋亡中发挥着重要作用。在本研究中,我们研究了 miRNA 在尤文肉瘤/原始神经外胚层肿瘤(EWS)化疗耐药中的可能作用。

方法

我们筛选多柔比星(Dox)耐药的 EWS 细胞,以鉴定可能调节 EWS 细胞化疗耐药性的独特 miRNA 序列。使用化疗敏感性测定评估 miRNA 的作用。使用基于网络的预测程序预测 miRNA 的可能靶基因。

结果

我们发现两种不同的 Dox 耐药 EWS 细胞系中 miR-125b 上调。在包括多柔比星在内的化疗方案存活的 EWS 肿瘤中也证实了 miR-125b 的上调。当 miR-125b 在 EWS 细胞中被敲低时,耐药和亲本细胞对多柔比星的敏感性均增强,这与促凋亡分子 p53 和 Bak 的上调有关。相反,miR-125b 在亲本 EWS 细胞中的过表达导致对多柔比星、依托泊苷和长春新碱的耐药性增强。

结论

我们的研究结果表明,miR-125b 通过抑制凋亡介质(如 p53 和 Bak)的表达,在 EWS 化疗耐药的发展中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/3599506/c49d3db4f246/1475-2867-13-21-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/3599506/d91f1089c7ee/1475-2867-13-21-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/3599506/1ab79596eabc/1475-2867-13-21-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/3599506/24c664a230c5/1475-2867-13-21-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/3599506/0ba2b669aa21/1475-2867-13-21-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/3599506/18c88c9eef5e/1475-2867-13-21-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/3599506/c49d3db4f246/1475-2867-13-21-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/3599506/d91f1089c7ee/1475-2867-13-21-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/3599506/1ab79596eabc/1475-2867-13-21-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/3599506/24c664a230c5/1475-2867-13-21-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/3599506/0ba2b669aa21/1475-2867-13-21-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/3599506/18c88c9eef5e/1475-2867-13-21-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/3599506/c49d3db4f246/1475-2867-13-21-6.jpg

相似文献

1
miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor.miR-125b 促进尤文肉瘤/原始神经外胚层肿瘤的化疗耐药性。
Cancer Cell Int. 2013 Mar 4;13(1):21. doi: 10.1186/1475-2867-13-21.
2
miRNA expression patterns in chemoresistant breast cancer tissues.化疗耐药乳腺癌组织中的微小RNA表达模式
Biomed Pharmacother. 2014 Oct;68(8):935-42. doi: 10.1016/j.biopha.2014.09.011. Epub 2014 Oct 5.
3
EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.EWS/FLI1 通过调节 miRNA-708 调控 Ewing 肉瘤中的 EYA3,导致细胞存活和化疗耐药性增加。
Mol Cancer Res. 2012 Aug;10(8):1098-108. doi: 10.1158/1541-7786.MCR-12-0086. Epub 2012 Jun 20.
4
miR-125b regulates the drug-resistance of breast cancer cells to doxorubicin by targeting HAX-1.微小RNA-125b通过靶向HAX-1调控乳腺癌细胞对阿霉素的耐药性。
Oncol Lett. 2018 Feb;15(2):1621-1629. doi: 10.3892/ol.2017.7476. Epub 2017 Nov 23.
5
MicroRNA-638 inhibits cell growth and tubule formation by suppressing VEGFA expression in human Ewing sarcoma cells.微小 RNA-638 通过抑制人尤文肉瘤细胞中 VEGFA 的表达来抑制细胞生长和管腔形成。
Biosci Rep. 2018 Jan 19;38(1). doi: 10.1042/BSR20171017. Print 2018 Feb 28.
6
[Down-Regulation of MiR-125b Reverses Drug Resistance of Doxorubicin-Resistant Leukemia Cells].[微小RNA-125b的下调逆转多柔比星耐药白血病细胞的耐药性]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Dec;26(6):1610-1615. doi: 10.7534/j.issn.1009-2137.2018.06.005.
7
The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.miR-125b-线粒体-半胱天冬酶-3通路在人类乳腺癌阿霉素耐药及治疗中的作用
Tumour Biol. 2015 Sep;36(9):7185-94. doi: 10.1007/s13277-015-3438-7. Epub 2015 Apr 17.
8
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.miR-34a 可预测尤文肉瘤患者的生存情况,并直接影响细胞的化疗敏感性和恶性程度。
J Pathol. 2012 Apr;226(5):796-805. doi: 10.1002/path.3007.
9
MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.微小RNA-125b通过抑制促凋亡的Bcl-2拮抗剂杀手1(Bak1)的表达赋予乳腺癌细胞对紫杉醇的抗性。
J Biol Chem. 2010 Jul 9;285(28):21496-507. doi: 10.1074/jbc.M109.083337. Epub 2010 May 11.
10
A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs.尤文肉瘤中涉及 IGF 通路靶向的新型致癌机制,由 EWS/Fli1 调节的 microRNAs 介导。
Oncogene. 2011 Dec 8;30(49):4910-20. doi: 10.1038/onc.2011.197. Epub 2011 Jun 6.

引用本文的文献

1
The Double Life of microRNAs in Bone Sarcomas: Oncogenic Drivers and Tumor Suppressors.微小RNA在骨肉瘤中的双重作用:致癌驱动因素和肿瘤抑制因子
Int J Mol Sci. 2025 May 17;26(10):4814. doi: 10.3390/ijms26104814.
2
The Landscape of microRNAs in Bone Tumor: A Comprehensive Review in Recent Studies.骨肿瘤 microRNAs 全景:近期研究全面综述。
Microrna. 2024;13(3):175-201. doi: 10.2174/0122115366298799240625115843.
3
Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma.

本文引用的文献

1
Camptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathways.喜树碱通过 microRNA-125b 介导的线粒体途径诱导癌细胞凋亡。
Mol Pharmacol. 2012 Apr;81(4):578-86. doi: 10.1124/mol.111.076794. Epub 2012 Jan 17.
2
miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells.miR-125b 和 miR-155 通过抑制 BCL2 表达和促进细胞增殖响应 CD40 配体(CD154)在人白血病 B 细胞中的作用。
J Biol Chem. 2012 Jan 20;287(4):2608-17. doi: 10.1074/jbc.M111.285718. Epub 2011 Dec 2.
3
MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo.
肿瘤微环境的综合分析揭示了肉瘤中与免疫浸润相关的预后 ceRNA 网络。
Clin Cancer Res. 2023 Oct 2;29(19):3986-4001. doi: 10.1158/1078-0432.CCR-22-3396.
4
Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review.非编码 RNA 在骨与软组织肉瘤的药物和放射抵抗中的作用:一项系统综述。
Elife. 2022 Nov 3;11:e79655. doi: 10.7554/eLife.79655.
5
The Biological Function of MicroRNAs in Bone Tumors.微小 RNA 在骨肿瘤中的生物学功能。
Int J Mol Sci. 2022 Feb 21;23(4):2348. doi: 10.3390/ijms23042348.
6
The Roles of microRNAs in Cancer Multidrug Resistance.微小RNA在癌症多药耐药中的作用
Cancers (Basel). 2022 Feb 21;14(4):1090. doi: 10.3390/cancers14041090.
7
Methylation-mediated silencing of protein kinase C zeta induces apoptosis avoidance through ATM/CHK2 inactivation in dedifferentiated chondrosarcoma.甲基化介导的蛋白激酶 C ζ沉默通过 ATM/CHK2 失活诱导去分化软骨肉瘤细胞逃避凋亡。
Br J Cancer. 2022 May;126(9):1289-1300. doi: 10.1038/s41416-021-01695-1. Epub 2022 Jan 11.
8
The Landscape of Regulatory Noncoding RNAs in Ewing's Sarcoma.尤因肉瘤中调控性非编码RNA的格局
Biomedicines. 2021 Jul 31;9(8):933. doi: 10.3390/biomedicines9080933.
9
Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy.循环细胞外囊泡是预测癌症治疗反应的有效生物标志物。
EBioMedicine. 2021 May;67:103365. doi: 10.1016/j.ebiom.2021.103365. Epub 2021 May 7.
10
Potential of the tumor‑derived extracellular vesicles carrying the miR‑125b‑5p target TNFAIP3 in reducing the sensitivity of diffuse large B cell lymphoma to rituximab.肿瘤衍生的细胞外囊泡携带 miR-125b-5p 靶向 TNFAIP3 降低弥漫性大 B 细胞淋巴瘤对利妥昔单抗敏感性的潜力。
Int J Oncol. 2021 Jun;58(6). doi: 10.3892/ijo.2021.5211. Epub 2021 Apr 23.
miR-125b 通过靶向 TP53INP1 肿瘤抑制因子在体内外促进 II 型子宫内膜癌细胞的增殖和迁移。
BMC Cancer. 2011 Oct 5;11:425. doi: 10.1186/1471-2407-11-425.
4
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.miR-34a 可预测尤文肉瘤患者的生存情况,并直接影响细胞的化疗敏感性和恶性程度。
J Pathol. 2012 Apr;226(5):796-805. doi: 10.1002/path.3007.
5
Macrophage infiltration predicts a poor prognosis for human ewing sarcoma.巨噬细胞浸润预示着人类尤文肉瘤预后不良。
Am J Pathol. 2011 Sep;179(3):1157-70. doi: 10.1016/j.ajpath.2011.05.034. Epub 2011 Jul 21.
6
miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.miR-125b 通过调控人类浸润性乳腺癌中的 ETS1 原癌基因而被甲基化,并发挥肿瘤抑制作用。
Cancer Res. 2011 May 15;71(10):3552-62. doi: 10.1158/0008-5472.CAN-10-2435. Epub 2011 Mar 28.
7
Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance?细胞适应机制:癌细胞何时以及如何产生化疗耐药性?
Cancer J. 2011 Mar-Apr;17(2):89-95. doi: 10.1097/PPO.0b013e318212dd3d.
8
MicroRNA miR-125b is a prognostic marker in human colorectal cancer.微小 RNA miR-125b 是人结直肠癌的一个预后标志物。
Int J Oncol. 2011 May;38(5):1437-43. doi: 10.3892/ijo.2011.969. Epub 2011 Mar 10.
9
Negative regulation of the tumor suppressor p53 gene by microRNAs.微小 RNA 对肿瘤抑制基因 p53 的负调控。
Oncogene. 2011 Feb 17;30(7):843-53. doi: 10.1038/onc.2010.457. Epub 2010 Oct 11.
10
miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes.miR-125b 通过靶向促凋亡基因促进前列腺癌异种移植瘤的生长。
Prostate. 2011 Apr;71(5):538-49. doi: 10.1002/pros.21270. Epub 2010 Sep 30.